The understanding of idiopathic intracranial hypertension (IIH) has evolved over the past few
years. Previously, IIH was considered a disease exclusively affecting the neuro-ophthalmic …

The monoclonal antibodies (mAbs) blocking the calcitonin-gene related peptide (CGRP)
pathway, collectively called here “anti-CGRP/rec mAbs”, have dramatically improved …

Pituitary adenylate cyclase-activating polypeptide-38 (PACAP-38), known for its role in
migraine pathogenesis, has been identified as a novel drug target. Given the clinical …

Posttraumatic headache (PTH) attributed to traumatic brain injury (TBI) is a secondary
headache developed within 7 days after head injury, and in a substantial number of patients …

ABSTRACT Primary Objective This is Part II of a four-part opinion review on traditional
neuropsychological assessment methods and findings associated with mild traumatic brain …

Background Posttraumatic headache (PTH) is a common and debilitating symptom following
repetitive mild traumatic brain injury (rmTBI), and it mainly resembles a migraine-like …

Repeat mild traumatic brain injuries (RmTBI) result in substantial burden to the public health
system given their association with chronic post-injury pathologies, such as chronic pain and …

Background Calcitonin gene-related peptide (CGRP) plays an important role in migraine
pathophysiology, and post-traumatic headache (PTH) frequently presents with migraine-like …

This review explores the application of the conservative management model for pain to
sports-related concussions (SRCs), framing concussions as a distinct form of pain syndrome …

ABSTRACT Introduction Calcitonin Gene-Related Peptide (CGRP)-targeted therapy has
revolutionized migraine treatment since its first approval in 2018. CGRP-targeted therapy …